Agents | Mechanism of action | Main effects | Indications | Side effects |
---|---|---|---|---|
Norepinephrine | α1+ > Β1 + | Vasoconstriction | First-line vasopressor in cardiogenic shock | Excessive vasoconstriction, immunomodulation |
Dobutamine | Β1+ | Ionotropy, moderate vasodilatation | First-line inotropic agent in cardiogenic shock | Tachycardia, hypotension (excessive vasodilatation) |
Milrinone | PD-3 inhibitor | Ionotropy | Second-line inotropic agent in CS | Tachyarrhythmias, hypotension, headache |
Levosimendan | Myofilament calcium sensitizer | Ionotropy and inodilator | Second-line inotropic agent in cardiogenic shock (patients under betablockers) | Hypotension, atrial and ventricular tachyarrhythmias, headache |